Calcium oxalate crystals in fetal bovine serum: Implications for cell culture, phagocytosis and biomineralization studies in vitro

Journal of Cellular Biochemistry

Volumn 103, Issue 5, 2008, Pages 1379-1393

  Pedraza, Claudio E ^a   Chien, Yung Ching ^a   McKee, Marc D ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Biomineralization; Calcium oxalate; Cell culture; Fetal bovine serum; Phagocytosis

Indexed keywords

CALCIUM OXALATE; CYTOKINE; REACTIVE OXYGEN METABOLITE;

ARTICLE; ATOMIC FORCE MICROSCOPY; BIOMINERALIZATION; CELL ADHESION; CELL CULTURE; CELL DISRUPTION; CELL MEMBRANE; CELL PROLIFERATION; CHEMICAL COMPOSITION; COMPUTER MODEL; CRYSTAL STRUCTURE; CRYSTALLIZATION; CULTURE MEDIUM; CYTOKINE RELEASE; DNA BINDING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOBLOTTING; MACROPHAGE; MEMBRANE DAMAGE; NONHUMAN; PHAGOCYTOSIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRECIPITATION; PRIORITY JOURNAL; PROTEIN BINDING; SCANNING ELECTRON MICROSCOPY; WESTERN BLOTTING; X RAY DIFFRACTION; X RAY MICROANALYSIS;

ANIMALS; BLOOD PROTEINS; CALCIUM OXALATE; CATTLE; CELL CULTURE TECHNIQUES; CELL LINE; MACROPHAGES; MICE; NIH 3T3 CELLS; OSTEOPONTIN; PHAGOCYTOSIS; SERUM;

BOVINAE;

EID: 41749089807     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21515     Document Type: Article

References (49)

1. Aderem A, Underhill DM. 1999. Mechanisms of phagocytosis in macrophages. Annu Rev Immunol 17:593-623.
2. Akbarieh M, Dubuc B, Tawashi R. 1987. Surface studies of calcium oxalate dihydrate single crystals during dissolution in the presence of urine. Scanning Microsc 1:1397-1403.
3. Bautista DS, Denstedt J, Chambers AF, Harris JF. 1996. Low-molecular-weight variants of osteopontin generated by serine proteinases in urine of patients with kidney stones. J Cell Biochem 61:402-409.
4. Belliveau J, Griffin H. 2001. The solubility of calcium oxalate in tissue culture media. Anal Biochem 291:69-73.
5. Bratosin D, Mitrofan L, Palii C, Estaquier J, Montreuil J. 2005. Novel fluorescence assay using calcein-AM for the determination of human erythrocyte viability and aging. Cytometry A 66:78-84.
6. Burns JR, Finlayson B. 1980. Changes in calcium oxalate crystal, morphology as a function of concentration. Invest Urol 18:174-177.
7. Cerini C, Geider S, Dussol B, Hennequin C, Daudon M, Veesler S, Nitsche S, Boistelle R, Berthezene P, Dupuy P, Vazi A, Berland Y, Dagorn JC, Verdier JM. 1999. Nucleation of calcium oxalate crystals by albumin: Involvement in the prevention of stone formation. Kidney Int 55:1776-1786.
8. Cheung HS. 2005. Biologic effects of calcium-containing crystals. Curr Opin Rheumatol 17:336-340.
9. Chiriboga J. 1963. Some properties of an oxalic oxidase purified from barley seedlings. Biochem Biophys Res Commun 11:277-282.
10. de Water R, Leenen PJ, Noordermeer C, Nigg AL, Houtsmuller AB, Kok DJ, Schroder FH. 2001. Cytokine production induced by binding and processing of calcium oxalate crystals in cultured macrophages. Am J Kidney Dis 38:331-338.
11. Elliot JS, Rabinowitz IN. 1980. Calcium oxalate crystalluria: Crystal size in urine. J Urol 123:324-327.
12. El-Shall H, Jeon J-H, Abdel-Aal EA, Khan S, Gower L, Rabinovich Y. 2004. A study of primary nucleation of calcium oxalate monohydrate. II. Effect of urinary species. Cryst Res Technol 39:222-229.
13. Finklea HO, Hanshew DD. 1992. Electron-transfer kinetics in organized thiol monolayers with attached pentaammine(pyridine)ruthenium redox centers. J Am Chem Soc 114:3173-3181.
14. Franceschi RT, Iyer BS. 1992. Relationship between collagen synthesis and expression of the osteoblast phenotype in MC3T3-E1 cells. J Bone Miner Res 7:235-246.
15. Franceschi VR, Nakata PA. 2005. Calcium oxalate in plants: Formation and Function. Annu Rev Plant Biol 56:41-71.
16. Greene EL, Farell G, Yu S, Matthews T, Kumar V, Lieske JC. 2005. Renal cell adaptation to oxalate. Urol Res 33:340-348.
17. Hassoun EA, Wang X. 1999. Time- and concentration-dependent production of superoxide anion, nitric oxide, DNA damage and cellular death by ricin in the J774A.1 macrophage cells. J Biochem Mol Toxicol 13:179-185.
18. Heiss A, DuChesne A, Denecke B, Grotzinger J, Yamamoto K, Renne T, Jahnen-Dechent W. 2003. Structural basis of calcification inhibition by alpha 2-HS glycoprotein/fetuin-A. Formation of colloidal calciprotein particles. J Biol Chem 278:13333-13341.
19. Honn KV, Singley JA, Chavin W. 1975. Fetal bovine serum: A multivariate standard. Proc Soc Exp Biol Med 149:344-347.
20. Kashtock M, Breder CV. 1980. Migration of ethylene glycol from polyethylene terephthalate bottles into 3% acetic acid. J Assoc Off Anal Chem 63:168-172.
21. Ketteler M, Vermeer C, Wanner C, Westenfeld R, Jahnen-Dechent W, Floege J. 2002. Novel insights into uremic vascular calcification: Role of matrix Gla protein and alpha-2-Heremans Schmid glycoprotein/fetuin. Blood Purif 20:473-476.
22. Khan SR. 2004. Role of renal epithelial cells in the initiation of calcium oxalate stones. Nephron Exp Nephrol 98:e55-e60.
23. Knight AP, Walter RG. 2003. A guide to plant poisoning of animals in North America. Ithaca: Teton NewMedia.
24. Konya E, Umekawa T, Iguchi M, Kurita T. 2003. The role of osteopontin on calcium oxalate crystal formation. Eur Urol 43:564-571.
25. Koul HK, Menon M, Chaturvedi LS, Koul S, Sekhon A, Bhandari A, Huang M. 2002. COM crystals activate the p38 mitogen-activated protein kinase signal transduction pathway in renal epithelial cells. J Biol Chem 277:36845-36852.
26. Lasaga AC. 1998. Theory of crystals growth and dissolution. Kinetic theory in the earth sciences. Princenton: Princenton University Press.
27. Lepage L, Tawashi R. 1982. Growth and characterization of calcium oxalate dihydrate crystals (Weddellite). J Pharm Sci 71:1059-1062.
28. Lieske JC, Walsh-Reitz MM, Toback FG. 1992. Calcium oxalate monohydrate crystals are endocytosed by renal epithelial cells and induce proliferation. Am J Physiol 262:F622-F630.
29. Lieske JC, Swift H, Martin T, Patterson B, Toback FG. 1994. Renal epithelial cells rapidly bind and internalize calcium oxalate monohydrate crystals. Proc Natl Acad Sci USA 91:6987-6991.
30. Marsh ME, Munne AM, Vogel JJ, Cui Y, Franceschi RT. 1995. Mineralization of bone-like extracellular matrix in the absence of functional osteoblasts. J Bone Miner Res 10:1635-1643.
31. McKee MD, Nanci A, Khan SR. 1995. Ultrastructural immunodetection of osteopontin and osteocalcin as major matrix components of renal calculi. J Bone Miner Res 10:1913-1929.
32. McMartin KE, Wallace KB. 2005. Calcium oxalate monohydrate, a metabolite of ethylene glycol, is toxic for rat renal mitochondrial function. Toxicol Sci 84:195-200.
33. Moe SM, Chen NX. 2004. Pathophysiology of vascular calcification in chronic kidney disease. Circ Res 95:560-567.
34. Navrotsky A. 2004. Energetic clues to pathways to biomineralization: Precursors, clusters, and nanoparticles. Proc Natl Acad Sci USA 101:12096-12101.
35. Olton D, Li J, Wilson ME, Rogers T, Close J, Huang L, Kumta PN, Sfeir C. 2007. Nanostructured calcium phosphates (NanoCaPs) for non-viral gene delivery: Influence of the synthesis parameters on transfection efficiency. Biomaterials 28:1267-1279.
36. Price PA, Thomas GR, Pardini AW, Figueira WF, Caputo JM, Williamson MK. 2002. Discovery of a high molecular weight complex of calcium, phosphate, fetuin, and matrix gamma-carboxyglutamic acid protein in the serum of etidronate-treated rats. J Biol Chem 277:3926-3934.
37. Price PA, Williamson MK, Nguyen TM, Than TN. 2004. Serum levels of the fetuin-mineral complex correlate with artery calcification in the rat. J Biol Chem 279:1594-1600.
38. Rolleston WB. 1999. Bovine serum: Reducing the variables through the use of donor herds. Dev Biol Stand 99:79-86.
39. Ryall RL. 2004. Macromolecules and urolithiasis: Parallels and paradoxes. Nephron Physiol 98:37-42.
40. Ryall RL, Chauvet MC, Grover PK. 2005. Intracrystalline proteins and urolithiasis: A comparison of the protein content and ultrastructure of urinary calcium oxalate monohydrate and dihydrate crystals. BJU Int 96:654-663.
41. Schafer C, Heiss A, Schwarz A, Westenfeld R, Ketteler M, Floege J, Muller-Esterl W, Schinke T, Jahnen-Dechent W. 2003. The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 112:357-366.
42. Schinke T, Amendt C, Trindl A, Poschke O, Muller-Esterl W, Jahnen-Dechent W. 1996. The serum protein alpha2-HS glycoprotein/fetuin inhibits apatite formation in vitro and in mineralizing calvaria cells. A possible role in mineralization and calcium homeostasis. J Biol Chem 271:20789-20796.
43. Sorensen ES, Petersen TE. 1993. Phosphorylation, glycosylation and amino acid sequence of component PP3 from the proteose peptone fraction of bovine milk. J Dairy Res 60:535-542.
44. Staines D, Price P. 2003. Managing serum requirements for cell culture: GIBCO cell culture. pp 1-6
45. Thamilselvan S, Byer KJ, Hackett RL, Khan SR. 2000. Free radical scavengers, catalase and superoxide dismutase provide protection from oxalate-associated injury to LLC-PK1 and MDCK cells. J Urol 164:224-229.
46. Thrall MA, Dial SM, Winder DR. 1985. Identification of calcium oxalate monohydrate crystals by X-ray diffraction in urine of ethylene glycol-intoxicated dogs. Vet Pathol 22:625-628.
47. Umekawa T, Chegini N, Khan SR. 2003. Increased expression of monocyte chemoattractant protein-1 (MCP-1) by renal epithelial cells in culture on exposure to calcium oxalate, phosphate and uric acid crystals. Nephrol Dial Transplant 18:664-669.
48. Walton RC, Kavanagh JP, Heywood BR, Rao PN. 2005. The association of different urinary proteins with calcium oxalate hydromorphs. Evidence for non-specific interactions. Biochim Biophys Acta 1723:175-183.
49. Webb MA. 1999. Cell-mediated crystallization of calcium oxalate in plants. Plant Cell 11:751-761.